Impact of discontinuation of serum antibody test reagents and COVID-19 pandemic on the diagnosis of amebiasis: A Japanese nationwide observational study
Authors:
- Yoshiro HadanoYHYoshiro Hadano
- Hirotake MoriHMHirotake Mori
- Satoshi OhnoSOSatoshi Ohno
Open Access
- 1 October 2026
- journal article
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
Abstract
No abstract availableFunding Information
- Shimane University
This publication has 8 references indexed in Scilit:
- Effects of Serum Antibody Test Reagent Discontinuation on Diagnosis of Amebiasis in Japan: Interrupted Time-Series AnalysisThe American Journal of Tropical Medicine and Hygiene, 2024
- Amebiasis as a sexually transmitted infection: A re-emerging health problem in developed countriesGlobal Health & Medicine, 2023
- Impact of the COVID-19 pandemic on the epidemiology of other communicable diseases in JapanInternational Journal of Infectious Diseases, 2023
- The impact of the COVID-19 pandemic on other infections differs by their route of transmission: A retrospective, observational study in JapanJournal of Infection and Chemotherapy, 2022
- A Review of the Global Burden, New Diagnostics, and Current Therapeutics for AmebiasisOpen Forum Infectious Diseases, 2018
- Epidemiology of Domestically Acquired Amebiasis in Japan, 2000–2013The American Journal of Tropical Medicine and Hygiene, 2016
- Entamoeba histolytica infection in men who have sex with menThe Lancet Infectious Diseases, 2012
- AmebiasisNew England Journal of Medicine, 2003